FDA inspection
Synergy Health AST, LLC: FDA inspection ending Mar 26, 2008
FDA inspection 513553 · Voluntary Action Indicated (VAI) · San Diego, CA
Key facts
| Inspection ID | 513553 |
|---|---|
| Firm | Synergy Health AST, LLC |
| FEI number | 1000518731 |
| Address | 9020 Activity Rd Ste D |
| City | San Diego |
| State | CA |
| ZIP | 92126-4454 |
| Fiscal year | 2008 |
| Inspection end date | Mar 26, 2008 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics, Devices, Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data